Solvmed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.77 M
- Revenue Growth 28.07%
- Profit Growth 49.74%
- Ebitda 16.31%
- Net Worth 17.95%
- Total Assets 34.92%
About Solvmed Pharmaceuticals
Solvmed Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2013 and has a history of 11 years and six months. Its registered office is in Darbhanga, Bihar, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.77 M.
Babloo Kumar and Reena Devi serve as directors at the Company.
Company Details
- Location
Darbhanga, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999BR2013PTC020941
- Company No.
020941
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Solvmed Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babloo Kumar  | Director | 14-Aug-2013 | Current |
| Reena Devi | Director | 14-Aug-2013 | Current |
Financial Performance of Solvmed Pharmaceuticals.
Solvmed Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.07% increase. The company also saw a substantial improvement in profitability, with a 49.74% increase in profit. The company's net worth Soared by an impressive increase of 17.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solvmed Pharmaceuticals?
In 2017, Solvmed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adino Lifecare Private LimitedBabloo Kumar is a mutual person
Charges (Loans)
₹0.77 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2021 | Hdfc Bank Limited | ₹0.77 M | Open |
How Many Employees Work at Solvmed Pharmaceuticals?
Unlock and access historical data on people associated with Solvmed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solvmed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solvmed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.